Medicine
Kybella 20 mg/2 mL injection
Kybella 20 mg/2 mL injection is a prescription medicine containing Deoxycholic acid for subcutaneous use, marketed by Kythera Biopharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions are permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Deoxycholic acid
- Brand
- Kybella
- Strength
- 20 mg/2 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 4 vials of 2 mL
- Marketing authorisation holder
- Kythera Biopharmaceuticals
- Manufacturer
- Kythera Biopharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions are permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D11AX24 Deoxycholic acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 June 2015
- Identifiers
- RxCUI 1649975, 1649980DailyMed set ID fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553NDC 61168-101Application NDA206333
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 4 vial, glass in 1 carton / 2 mL in 1 vial, glass | 61168-101-04 | Kythera Biopharmaceuticals | 8 June 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 April 2015 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Deoxycholic acid is a cytolytic agent indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. It is available as injection for subcutaneous use. MedsAcross supplies Deoxycholic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Deoxycholic acidFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KYBELLA prescribing information (Kythera Biopharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Kybella 20 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.